Makita N, Yasuda H
Department of Cardiovascular Medicine, Hokkaido University School of Medicine, Sapporo, Japan.
Basic Res Cardiol. 1990 Sep-Oct;85(5):435-43. doi: 10.1007/BF01931489.
In order to determine whether phosphoinositide metabolism is altered in hypertensive cardiac hypertrophy, phospholipase C (PLC) and protein kinase C activities were measured in hearts from 4- and 20-week-old spontaneously hypertensive rats (SHR) and age-matched, normotensive Wistar-Kyoto rats (WKY). PLC activities were assayed using phosphatidylinositol (PI) and phosphatidylinositol-4,5-bisphosphate (PIP2) as substrates to assess the substrate specificity. PI-hydrolyzing PLC activity (PI-PLC) was predominantly located in the cytosol, and its activity was similar in both strains. Membrane-bound PIP2-hydrolyzing PLC activity (PIP2-PLC) was significantly lower in 20-week-old SHR than in WKY, but there was no significant difference in soluble PIP2-PLC. Protein kinase C activity was significantly elevated in 20-week-old SHR and Ca2(+)-phospholipid-dependent phosphorylation was observed in the proteins of molecular weight 26, 32, 43, and 95 KDa. In 4-week-old prehypertensive SHR, there were no significant differences in PI-PLC, PIP2-PLC, or protein kinase C activities as compared with age-matched WKY. These data demonstrated that protein kinase C and membrane-bound PIP2-PLC are altered during the period of hypertension development. These alterations may have important roles in the development or maintenance of hypertensive cardiac hypertrophy in SHR.
为了确定高血压性心肌肥厚时磷酸肌醇代谢是否改变,我们测定了4周龄和20周龄自发性高血压大鼠(SHR)以及年龄匹配的正常血压Wistar-Kyoto大鼠(WKY)心脏中的磷脂酶C(PLC)和蛋白激酶C活性。使用磷脂酰肌醇(PI)和磷脂酰肌醇-4,5-二磷酸(PIP2)作为底物测定PLC活性,以评估底物特异性。PI水解PLC活性(PI-PLC)主要位于胞质溶胶中,两种品系中的活性相似。20周龄SHR中膜结合的PIP2水解PLC活性(PIP2-PLC)显著低于WKY,但可溶性PIP2-PLC无显著差异。20周龄SHR中蛋白激酶C活性显著升高,且在分子量为26、32、43和95 kDa的蛋白质中观察到Ca2(+)-磷脂依赖性磷酸化。在4周龄的高血压前期SHR中,与年龄匹配的WKY相比,PI-PLC、PIP2-PLC或蛋白激酶C活性无显著差异。这些数据表明,在高血压发展过程中蛋白激酶C和膜结合的PIP2-PLC发生了改变。这些改变可能在SHR高血压性心肌肥厚的发生或维持中起重要作用。